期刊文献+

转化生长因子β与硬皮病临床分类的关系 被引量:3

The Relationship Between the Expression of TGF-β and the Types of Scleroderma
原文传递
导出
摘要 目的 通过对SD患者皮损中TGF -β1 、β2 mRNA和蛋白表达水平的检测 ,探讨TGF -β1 、β2 mRNA和蛋白在SD的发病机制中的作用 ,探讨TGF -β1 、β2 mRNA和蛋白与SD临床分类间的关系。方法 采用原位逆转录聚合酶链反应 (原位RT -PCR)技术和免疫组化SP方法 ,检测 17例SD患者皮损中TGF -β1 、β2 mRNA和蛋白的表达情况 ,并以 10例正常皮肤组织作为对照。结果 ①TGF -β1 mRNA在SD组表达阳性率、表达程度和积分值高于对照组 ;但TGF -β1 mRNA在局限性SD组和SSc组表达阳性率相近。②TGF -β1 、β2 蛋白在SD组表达阳性率、表达程度和积分值均明显高于对照组 ;而TGF -β1 、β2 蛋白在局限性SD组和SSc组表达阳性率均为 10 0 %。结论 ①SD组TGF -β1 mRNA表达阳性率和表达程度均增高 ,表明TGF -β1 mRNA在SD纤维化过程中起重要作用。②SD组TGF -β1 、β2 蛋白表达阳性率和表达程度均明显增高 ,显示TGF -β1 、β2 蛋白与SD皮肤纤维化有密切关系。③TGF -β1 、β2mRNA和蛋白的表达与SD的临床分类无相关性 。 Objective To investigate the role of TGF-β 1 and -β 2 in the pathogenesis of scleroderma(SD) and the relationship between this kind of cytokines and the clinical types of SD. Methods The TGF-β 1 and -β 2 mRNA and protein expressions in lesions of 17 patients with SD and 10 normal controls were detected using in situ RT-PCR technique and immunohistochemistry SP assay respectively. Results ①The positive rate and the expression strength of TGF-β 1 mRNA expression in the SD group were much higher than those in control group. There was no difference in TGF-β 1 mRNA expression between the localized SD and SSc patients. ②The positive rate and expression strength of TGF-β 1 and -β 2 proteins in SD group were much higher than those in control group. There was no difference in TGF-β 1 and -β 2 protein expressions between localized SD and SSc cases. Conclusion ①The positive rate and expression strength of TGF-β 1 mRNA in SD patients increased, which implied that TGF-β 1 mRNA may play an important role in fibrosis of SD. ②The positive rate and expression strength of TGF-β 1 and -β 2 proteins were more elevated in SD,which suggested that TGF-β 1 and -β 2 proteins were associated with skin fibrosis of SD. ③There was no relationship between the expression of TGF-β 1 and TGF-β 2 mRNA or proteins and the clinical types of SD, which indicated that there may be a similar pathogenesis for localized SD and SSc.
出处 《中国医师杂志》 CAS 2004年第3期313-315,共3页 Journal of Chinese Physician
关键词 转化生长因子Β 硬皮病 细胞因子 原位RT-PCR 免疫组化SP法 发病机制 结缔组织病 Transforming growth factor-β 1 (TGF-β 1) Transforming growth factor-β 2 (TGF-β 2) Scleroderma
  • 相关文献

参考文献11

  • 1Yamamoto T, Takagawa S, Katayama I, et al. Anti - sclerotic effect of TGF- β antibody in a mouse model of bleomycin - induced scleroderma[J]. Clin Immonol, 1999, 92(1): 6-13.
  • 2Rui M, Santos, Pamela N, et al. TGF -β isoforms in alcoholic liver disease[J]. J Gastroenterol. 1998, 33: 383-389.
  • 3Shimizu M, Saitoh Y, Itoh H, et al. Immunohistochemical staining of haras oncogene product in normal , benign, and malignant human pancreatic tissues[J]. Human Pathol. 1990. 21:607-613.
  • 4Kulozik M, Hogg A. Lankat - Buttgereit B, et al. Colacalization of transforming growth factor beta 2 with alpha 1 ( 1 ) procollagen mRNA in tissue sections of patients with systemic sclerosis[J]. J Clin Invest. 1990. 86:917 - 922.
  • 5Gruschwitz M, Muller P, Sepp N. et al. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis[J]. J Invest Dermatol. 1990, 94:365 - 371.
  • 6Sfikakis, Peter P, Bryan K, et al. Immunohistological Demonstration of transforming growth factor -β isoforms in the skin of palients with systemic sclerosis[J]. Clinical Immunology and Immunopathology. 1993,69(2): 199- 204.
  • 7Higley K, Persichitte S, Chu W, et al. Immunocytochemical localization and serologic detection of transforming growth factor β1 [J]. Arth and Rheum,1994, 37(2):278 - 288.
  • 8Lepoole IC, Boyce ST. Keratinocytes suppress TGF -β1 expression by fibroblasts in cultured skin substitutes[J]. J Dermatol. 1999, 140(3). 409 - 416.
  • 9Kawakami T, Ihn H, Xu W, et al. Increased expression of TGF - β receptors by scleroderma fibroblasts : Evidence for contribution of autocrine TGF -β signaling to scleroderma phentotype[J]. J Invest Dermatol, 1998, 110(1): 47-51.
  • 10Raghunath M, Unsold C, Kubitscheck U, et al. The cutaneous microfibrillar apparatus contains latent transforming growth factor-β binding protein -1 and is a repository for latent TGF -β1[J]. J Invest Dermatol, 1998 , 111(4) : 559 - 564.

同被引文献29

  • 1Ihn H.Pathogenesis of fibrosis:role of TGF-[beta] and CTGF[J].Cur Opinion Rheumatol,2002,14(6):681-685.
  • 2Boesen CC,Radaev S,Motyka SA,et al.The 1.1 A crystal structure of human TGF-beta type Ⅱ receptor ligand binding domain[J].Structure,2002,10(7):913-919.
  • 3Anonymous.Preliminary criteria for the classification of systemic sclerosis(scleroderma).Subcommittee for scleroderma criteria of the American Rheumati-sm Association Diagnostic and Therapeutic Criteria Committee[J].Arthritis Rheu,1980,23 (5):581-90.
  • 4Schuster N,Krieglstein K.Mechanisms of TGF-beta-mediated apoptosis[J].Cell Tissue Res,2002,307(1):11-14.
  • 5Palmer EM,Beilfuss BA,Nagai T,et al.Human helper T cell activation and differentiation is suppressed by porcine small intestinal submucosa[J].Tissue Eng,2002,8(5):893-900.
  • 6Paradis H,Liu CY,Saika S,et al.Tubedown-1 in remodeling of the developing vitreal vasculature in vivo and regulation of capillary outgrowth in vitro[J].Dev Biol,2002,249(1):140-155.
  • 7Blobe GC,Schiemann WP,Pepin MC,et al.Functional roles for the cytoplasmic domain of the type Ⅲ transforming growth factor beta receptor in regulating transforming growth factor beta signaling[J].J Biol Chem,2001,276(27):24627-24637.
  • 8Fortuno ES 3rd,LeSueur JA,Graff JM.The amino terminus of Smads permits transcriptional specificity[J].Dev Biol,2001,230(2):110-124.
  • 9Higley K,Persichitte S,Chu W,et al.Immunocytochemical localization and serologic detection of transforming growth factor β1[J].Arth Rheum,1994,37(2):278-288.
  • 10Ihn H.The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma[J].Arc Immunol Ther Exp,2002,50(5):325-331.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部